Replacing Pseudoephedrine Easier Said Than Done, OTC Firms Find
This article was originally published in The Tan Sheet
Executive Summary
Reformulating pseudoephedrine products has posed a greater challenge than expected for a number of firms, as passage of a federal bill restricting sale of the ingredient looms